Enteric Plesiomonas shigelloides infections in Finnish patients

Scandinavian Journal of Infectious Diseases
H RautelinT U Kosunen

Abstract

Plesiomonas shigelloides was isolated from 20/13,027 stool samples submitted for culture to the Department of Bacteriology and Immunology, University of Helsinki, in 1990. All except 2/20 Plesiomonas-positive patients had diarrhea; 13 patients had acute onset of illness after foreign travel and 5 patients had chronic diarrhea with symptoms lasting > or = 2 months. Travel destinations were outside Europe in most cases. In 12 cases Plesiomonas was isolated in pure culture and in 8 cases together with other enteropathogens. All isolates were susceptible to ciprofloxacin, doxycycline, trimethoprim and sulfamethoxazole, gentamicin, cephalexin, cefuroxime, ceftriaxone and cefixime.

References

Apr 1, 1978·The Journal of Hygiene·T TsukamotoR Sakazaki
Jan 1, 1991·Journal of Clinical Microbiology·S L AbbottJ M Janda
Apr 1, 1989·Scandinavian Journal of Gastroenterology·H I RautelinT U Kosunen
May 1, 1989·Journal of Clinical Microbiology·K C Kain, M T Kelly
Feb 16, 1985·Lancet·D N TaylorB G Weniger
Apr 1, 1987·Infection and Immunity·D A HerringtonM M Levine
Nov 1, 1986·Annals of Internal Medicine·S D HolmbergJ J Farmer
Jul 1, 1985·Infection·A Ljungh, T Wadström
Sep 1, 1984·Reviews of Infectious Diseases·S D Holmberg, J J Farmer
Sep 1, 1984·Journal of Clinical Microbiology·K V Rolston, R L Hopfer
May 1, 1982·Journal of Clinical Microbiology·R G PennL C Preheim
Jan 1, 1995·Scandinavian Journal of Infectious Diseases·H RautelinT U Kosunen

❮ Previous
Next ❯

Citations

Feb 24, 2004·Folia Microbiologica·A Hostacká, I Ciznár
May 18, 2011·Folia Microbiologica·Carlos González-ReyKarel Krovacek
Dec 24, 2003·Comparative Immunology, Microbiology and Infectious Diseases·Carlos González-ReyKarel Krovacek
Feb 5, 2000·Comparative Immunology, Microbiology and Infectious Diseases·K KrovacekI Ciznar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.